FDA Panel Says OK to New Use for Eye Drug

WASHINGTON (MedPage Today) -- An FDA advisory committee voted unanimously on Thursday to recommend approval of a new indication for ranibizumab (Lucentis) for the treatment of diabetic macular edema.

Full Story →